ACS CAN Comments on FDA Guidance on Integrating Randomized Controlled Trials into Routine Clinical Practice

ACS CAN submitted comments on draft U.S. Food and Drug Administration (FDA) guidance on Integrating Randomized Controlled Trials for Drug and Biological Products into Routine Clinical Practice.